« Back
Home /
Amikacin (disulfate)

Amikacin (disulfate)

Item no.	HY-B0509B-10mM
Manufacturer	MedChem Express
CASRN	39831-55-5
Amount	10 mM/1 mL
Quantity options	10 mM/1 mL 1 g 500 mg 5 g
Category	Food Safety Antibiotics Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	98.0
Citations	[1]Edson, R.S. and C.L. Terrell, The aminoglycosides. Mayo Clin Proc, 1999. 74(5): p. 519-28.\|[2]Ristuccia AM, et al. An overview of amikacin. Ther Drug Monit. 1985;7(1):12-25.\|[3]Siân R Kitcher, et al. ORC-13661 Protects Sensory Hair Cells From Aminoglycoside and Cisplatin Ototoxicity. JCI Insight. 2019 Aug 8;4(15):e126764. ACS Chem Biol. 2022 Jan 21;17(1):39-53. bioRxiv. 2024 May 10. Int J Antimicrob Agents. 2018 Aug;52(2):269-271. Nat Commun. 2022 Mar 2;13(1):1116. ACS Infect Dis. 2024 Apr 12;10(4):1327-1338. AMB Express. 2024 Dec 24;14(1):141. Antimicrob Agents Chemother. 2024 Oct 29:e0094524. Antimicrob Agents Chemother. 2025 May 23:e0024925. Authorea. 2025 Sep 17. bioRxiv. 2025 May 30. Commun Biol. 2025 Oct 6;8(1):1425. EBioMedicine. 2025 May 30:117:105776. Eur J Clin Microbiol Infect Dis. 2025 Jun;44(6):1493-1500. Eur J Clin Microbiol Infect Dis. 2025 Sep 29. Int J Antimicrob Agents. 2025 Jun 9:107551. Int J Med Microbiol. 2023 Mar 28;313(2):151578. J Antimicrob Chemother. 2020 Sep 1;75(9):2609-2615. J Clin Microbiol. 2025 Aug 20:e0084125. Microbiol Spectr. 2025 May 19:e0307424. Pathogens. 2025 Mar 21;14(4):302. Antibiotics (Basel). 2021 Sep 14;10(9):1110. Appl Microbiol Biotechnol. 2022 Apr;106(7):2689-2702. Curr Microbiol. 2021 Dec 14;79(1):12. J Antimicrob Chemother. 2020 Jul 1;75(7):1850-1858.
Smiles	OS(O)(=O)=O.OS(O)(=O)=O.O[C@@H]1[C@H]([C@@H](C[C@H](N)[C@H]1O[C@@]([C@@H]([C@@H](O)[C@@H]2O)O)([H])O[C@@H]2CN)NC([C@@H](O)CCN)=O)O[C@@]([C@@H]([C@@H](N)[C@@H]3O)O)([H])O[C@@H]3CO
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BAY 41-6551 (disulfate)
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Category	Reference compound / Active compounds; API
Manufacturer - Targets	Antibiotic; Bacterial
Manufacturer - HS Code	H315, H319, H335, H350, H360
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture)
Molecular Weight	781.76
Product Description	Amikacin disulfate (BAY 41-6551 dissulfate) is an aminoglycoside antibiotic and a semisynthetic analog of kanamycin. Amikacin disulfate is bactericidal, acting directly on the 30S and 50S bacerial ribosomal subunits to inhibit protein synthesis. Amikacin disulfate is very active against most Gram-negative bacteria including gentamicin- and tobramycin-resistant strains. Amikacin disulfate also inhibits the infections caused by susceptible Nocardia and nontuberculous mycobacteria[1][2].
Manufacturer - Research Area	Infection; Cancer
Solubility	DMSO : < 1 mg/mL\|H2O : 100 mg/mL (ultrasonic)
Manufacturer - Pathway	Anti-infection
Clinical information	Launched
Isoform	Aminoglycoside
UNSPSC Code	12352005
Precautionary	H315, H319, H335, H350, H360

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.